Letters from the ECCO President
04October2018

Letter from the ECCO President

Silvio Danese, ECCO President

Silvio Danese
Silvio Danese 
©  ECCO

Dear ECCO friends,

Summer has passed and I truly hope you had a great vacation.

We are approaching fall with great enthusiasm and looking forward to the new Educational Activities that are scheduled for the upcoming 14th Congress of ECCO, which will be held in Copenhagen in March 2019. In order to enhance competence and knowledge in IBD and patients’ care, education is one of our top priorities.

Posted in ECCO News, Letters from the ECCO President, Volume 13, Issue 3

08June2018

Letter from the ECCO President

Silvio Danese, ECCO President

Silvio Danese
Silvio Danese 
©  ECCO

Dear ECCO friends,

Improving the care of IBD patients is one of ECCO’s most valuable purposes. This goal is achieved through enhancement of our knowledge of Inflammatory Bowel Diseases. Two programmes highlighted in this issue of ECCO News move in this direction: The UR-CARE database, which seeks to achieve this goal through intense collaboration between researchers in Europe via a shared database, and the e-CCO Learning Platform, which many of you had the opportunity to experience during the 13th ECCO Congress in Vienna. This intiative is particularly exciting because it offers physicians a tool to fill in learning gaps using the ECCO IBD Curriculum. Both of these tools will contribute to reinforce the excellence of IBD centres.

Posted in ECCO News, Volume 13, Issue 2, Letters from the ECCO President

27April2018

Letter from the ECCO President

Silvio Danese, ECCO President

Silvio Danese
Silvio Danese 
©  ECCO

Dear ECCO friends,

Thank you to everyone for once again making the ECCO Congress, Europe’s most important event in the field of Inflammatory Bowel Disease (IBD), such a wonderful occasion. Held this year in Vienna, the Congress attracted 6,676 participants from over 80 countries and the number of accepted abstracts surpassed 1,000.  Thank you especially to our invited speakers for delivering such exciting presentations and also to the ECCO Committee Members for their hard work and dedication, which helped to make the Congress so successful. 

Posted in ECCO News, Volume 13, Issue 1, Letters from the ECCO President

12December2017

Letter from the ECCO President

Julián Panés, ECCO President

Julian PanesJulián Panés  ©  ECCO

Dear ECCO friends,

We are witnessing an exciting period in the development of new therapies for Inflammatory Bowel Diseases. New therapeutic targets, and new classes of drugs, are being integrated into our therapeutic armamentarium. However, when we consider the proportion of patients who respond to induction therapy and, among those, the fraction who achieve remission during maintenance, the percentage of initially treated patients in whom the disease is satisfactorily controlled over one year does not exceed 15%30%.

Posted in ECCO News, Volume 12, Issue 4, Letters from the ECCO President